Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S. Int J Chron Obstruct Pulmon Dis. 2020;15:745–754.
The authors have advised there is an error in on page 751. The Q2 subgroup of the placebo arm has the label of “−0.012” which should read “0.012”.
The correct is shown below. The authors apologize for this error.
Figure 4 Pooled analysis of change from baseline in trough FEV1 at 12 weeks by baseline rescue medication use subgroup (ITT population).
Abbreviations: BID, twice daily; FEV1, forced expiratory volume in 1 second; GLY, nebulized glycopyrrolate; ITT, intent-to-treat; LS, least squares; Q, quarter; SE, standard error.
![Figure 4 Pooled analysis of change from baseline in trough FEV1 at 12 weeks by baseline rescue medication use subgroup (ITT population).](/cms/asset/53ba4c1d-8c95-4624-85ab-b4b12c6708e8/dcop_a_12198286_f0001_c.jpg)